Patent Assignment
Reel/Frame 066375/0162
Assignment of Assignor's Interest
Recorded: 2024-01-26
Pages: 27
Assignor
ESBATECH, A NOVARTIS COMPANY LLC
Executed: 2019-05-08
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(3)
Sequence Based Engineering and Optimization of Single Chain Antibodies
Sequence based engineering and optimization of single chain antibodies
Application:
60/937,112 →
Sequence based engineering and optimization of single chain antibodies
Application:
61/069,057 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 21, 2007
From: URECH, DAVID; BORRAS, LEONARDO
To: ESBATECH AG
Reel/Frame 019868/0428 →
Assignment of Assignor's Interest
Dec 11, 2008
From: URECH, DAVID; BORRAS, LEONARDO
To: ESBATECH AG
Reel/Frame 021964/0444 →
Assignment of Assignor's Interest
Feb 11, 2009
From: URECH, DAVID; BORRAS, LEONARDO
To: ESBATECH AG
Reel/Frame 022239/0773 →
Change of Name
Dec 11, 2009
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT GMBH
Reel/Frame 023639/0314 →
Corrective Assignment to Correct the Legal Status of the Assignee as Llc, Not Gmbh Previously Recorded on Reel 023639 Frame 0314. Assignor(S) Hereby Confirms the Legal Status of the Assignee Is Esbatech, an Alcon Biomedical Research Unit Llc.
Jan 4, 2010
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 023720/0976 →
Assignment of Assignor's Interest
Dec 13, 2018
From: ESBATECH, A NOVARTIS COMPANY LLC
To: NOVARTIS AG
Reel/Frame 047768/0136 →